The Japanese encephalitis (JE) vaccine provides strong protection for at least one year after the primary series, with most people retaining protective antibody levels for several years beyond that. If you continue to be at risk, a booster dose is recommended one year or more after your initial vaccination. How long your immunity actually lasts depends on the type of vaccine you received, your age, and whether you’ve had a booster.
Protection After the Primary Series
The most widely used JE vaccine for travelers is IXIARO, an inactivated vaccine given as two doses 28 days apart. Four weeks after completing that primary series, 99% of people have protective antibody levels. That number holds up well over time: at two years, about 91% of recipients still carry protective antibodies, and at five years, roughly 82% do.
These numbers come with a caveat. In one large follow-up study, people who had previously been vaccinated against tick-borne encephalitis (a related virus) retained protection at notably higher rates, with about 86% still protected at five years compared to only 64% of those without prior related vaccination. Your immune history with similar viruses can meaningfully influence how long protection lasts.
When You Need a Booster
The CDC recommends a booster dose if you received your two-dose primary series a year or more ago and you’re still at risk of exposure. This applies whether you’re planning another trip to an area where JE circulates or you live and work in a region where the virus is present. The booster is a single third dose of IXIARO.
There is no official recommendation for repeated boosters beyond this third dose. For most travelers, a single booster after the primary series is sufficient. If you live long-term in an area with ongoing JE transmission, talk with a travel medicine specialist about whether additional doses make sense for your situation.
How Age Affects Immunity
Age is one of the strongest predictors of how long your vaccine protection holds. Among younger adults, antibody retention is high and durable. In a Korean study that measured neutralizing antibodies across age groups, 100% of 15-year-olds with moderate antibody levels still had detectable protection years later. By age 70 and above, that figure dropped to about 60%.
Older adults also respond less robustly to the initial vaccination. In a study focused on adults aged 64 and older, only 65% had protective antibody levels six weeks after the primary series, compared to the 99% seen in the general adult population. If you’re vaccinated later in life, the window of reliable protection is shorter and the initial immune response may be weaker.
Live Vaccines Used in Asia
If you were vaccinated in an Asian country, you may have received a different product: the live attenuated SA 14-14-2 vaccine, which is the most commonly used JE vaccine worldwide. It’s given routinely to children in China (at 8 months and 2 years of age) and in South Korea (two doses 12 months apart, with a booster at age 6).
A single dose of this live vaccine produces 80% to 99% efficacy, and two doses push that above 98%. However, measurable antibody levels can drop significantly over time, especially in young children. In a study of children vaccinated between 10 and 12 months of age, only about 9% still had detectable protective antibodies three years later, and 12% at four years.
That low number is somewhat misleading, though. When those same children received a booster dose, over 91% mounted a rapid immune response within just seven days, and 98% were fully protected by four weeks. This suggests the immune system retains a “memory” of the virus even after circulating antibodies fade below measurable levels. The body can reactivate its defenses quickly when re-exposed or boosted.
What “Protected” Actually Means
Researchers define protection using a lab measurement called a neutralizing antibody titer. A titer of 1:10 or higher is considered the threshold for seroprotection. This means your blood contains enough antibodies to neutralize the virus in a standardized test. It’s important to understand that falling below this threshold doesn’t necessarily mean you’re completely unprotected. Immune memory cells can persist even when antibodies wane, as the live vaccine data in children demonstrates.
That said, higher antibody levels at the start correlate with longer-lasting protection. People who develop a robust initial response tend to stay above the protective threshold for more years than those with a weaker response. This is part of why older adults, who often produce fewer antibodies after vaccination, tend to lose measurable protection sooner.
Practical Takeaways for Travelers
If you’re a one-time traveler who got vaccinated years ago and now has another trip planned, the key question is whether it’s been more than a year since your primary series. If so, get the booster before you go. If you completed the two-dose series within the past year, you’re still well within the window of strong protection.
For people who travel frequently to JE-risk areas in South and Southeast Asia, the five-year data is reassuring. Most healthy adults retain protective antibodies for several years after the primary series, and a single booster extends that further. There’s no established need for routine re-vaccination every few years, but if you’re over 65 or have a condition that weakens your immune system, it’s reasonable to discuss your antibody status or booster timing with a travel health provider before trips to high-risk areas.